Intelligence Profile
Science
Mechanism of Action
Platelet-rich plasma (PRP) joint injections work through the concentrated delivery of growth factors and bioactive proteins contained within platelets directly to damaged joint tissues. When platelets are activated at the injection site, they release alpha granules containing numerous growth factors including platelet-derived growth factor (PDGF), transforming growth factor-beta (TGF-β), vascular endothelial growth factor (VEGF), and insulin-like growth factor (IGF-1).
The proposed mechanisms include:
Growth Factor Release: The concentrated platelets (typically 3-5 times baseline levels in PRP preparations) degranulate upon activation, releasing stored growth factors that theoretically promote tissue repair and regeneration in cartilage, synovium, and surrounding joint structures.
Anti-inflammatory Effects: Some evidence suggests PRP may modulate local inflammatory responses, though the specific molecular pathways remain under investigation.
Cellular Stimulation: The growth factors are thought to stimulate resident stem cells, chondrocytes, and other joint tissue cells to enhance repair processes and potentially slow degenerative changes.
Evidence Limitations: While multiple clinical trials have been completed evaluating PRP for knee osteoarthritis (including studies comparing leukocyte-rich versus leukocyte-poor preparations), the exact molecular mechanisms remain incompletely understood. The available evidence from recent studies focuses primarily on clinical outcomes rather than detailed mechanistic data. Comparative studies suggest variable efficacy, and the optimal PRP preparation, concentration, and injection protocols are still being refined.
This information is for educational purposes only and should not replace professional medical consultation. Individual treatment decisions should always be made in consultation with a qualified healthcare provider.